ANIDO ARMANDO (Chairman & Chief Exec. Officer) sold 5.8% of their position (35.45K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $21.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/25/2023ACC: 0001062993-23-001384
DirectorOfficer· Chairman & Chief Exec. Officer
Since Aug 2018
+214.55K
Net shares
Net buyer
$21.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
250K acquired · 35.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−35.45K
Price / share
$0.60
Trade value
$21.19K
% of position
5.8%
1/23/2023
611.69K→576.24K
Common Stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
43.4%
1/24/2023
576.24K→826.24K
Total
Net shares
+214.55K
Net value
-$21.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2023 | S · Sale | −35.45K | $0.60 | $21.19K | 5.8% | 611.69K | 576.24K |
| Common Stock Direct | 1/24/2023 | A · Award | +250K | — | — | 43.4% | 576.24K | 826.24K |
| Total | +214.55K | -$21.19K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned26.59K
Common Stock
IndirectShares owned13.30K
Total
39.89K indirect39.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.59K | Indirect |
| Common Stock | 13.30K | Indirect |
| Total | 39.89K | 39.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported